Dipal Doshi
SVP Business Planning & Dev, Amicus Therapeutics.
Companies
- Azenta Life SciencesBoard member Feb 4, 2025 to now1
- Entrada Therapeutics, Inc.Board member Oct 28, 2021 to now2
- Entrada Therapeutics, Inc.Chief executive officer Oct 28, 2021 to now2
- Entrada Therapeutics, Inc.President Oct 28, 2021 to Dec 22, 20232
- Amicus TherapeuticsSVP Business Planning & Dev Jul 8, 2014 to Jul 9, 20153
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Entrada Therapeutics, Inc. TRDA517,290 shares4$2.5M at $4.81Sep 2, 2026
Azenta Life Sciences AZTA9,703 shares5$342.6K at $35.31Feb 5, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 2, 2026Shares withheld for tax 8,724 shares at $7.14 of Entrada Therapeutics, Inc.4
- Mar 3, 2026Shares withheld for tax 19,181 shares at $11.76 of Entrada Therapeutics, Inc.6
- Mar 2, 2026Shares withheld for tax 9,869 shares at $11.66 of Entrada Therapeutics, Inc.6
- Mar 1, 2026Granted 139,400 shares of Entrada Therapeutics, Inc.6
- Feb 5, 2026Granted 5,663 shares at $27.85 of Azenta Life Sciences5
- Sep 2, 2025Shares withheld for tax 8,723 shares at $5.43 of Entrada Therapeutics, Inc.7
- Mar 3, 2025Shares withheld for tax 17,566 shares at $11.68 of Entrada Therapeutics, Inc.8
- Mar 1, 2025Granted 116,200 shares of Entrada Therapeutics, Inc.8
- Feb 7, 2025Granted 4,040 shares at $52.32 of Azenta Life Sciences9
- Sep 5, 2024Shares withheld for tax 826 shares at $15.13 of Entrada Therapeutics, Inc.10
- Sep 4, 2024Shares withheld for tax 4,744 shares at $15.42 of Entrada Therapeutics, Inc.10
- Sep 3, 2024Shares withheld for tax 72 shares at $17.70 of Entrada Therapeutics, Inc.10
- Sep 3, 2024Shares withheld for tax 752 shares at $16.93 of Entrada Therapeutics, Inc.10
- Sep 3, 2024Shares withheld for tax 2,328 shares at $15.76 of Entrada Therapeutics, Inc.10
- Jul 15, 2024Sold 1,600 shares at $17.81 of Entrada Therapeutics, Inc.11
- Jul 12, 2024Sold 300 shares at $18.00 of Entrada Therapeutics, Inc.11
- Jun 13, 2024Sold 1,000 shares at $16.17 of Entrada Therapeutics, Inc.12
- May 17, 2024Sold 1,200 shares at $15.11 of Entrada Therapeutics, Inc.13
- May 16, 2024Sold 1,800 shares at $15.00 of Entrada Therapeutics, Inc.13
- Mar 5, 2024Shares withheld for tax 5,049 shares at $12.28 of Entrada Therapeutics, Inc.14
- Mar 4, 2024Shares withheld for tax 1,391 shares at $13.37 of Entrada Therapeutics, Inc.14
- Mar 4, 2024Shares withheld for tax 1,164 shares at $12.42 of Entrada Therapeutics, Inc.14
- Mar 1, 2024Granted 104,700 shares of Entrada Therapeutics, Inc.14
- Feb 15, 2024Sold 1,000 shares at $15.00 of Entrada Therapeutics, Inc.15
- Jan 16, 2024Sold 1,000 shares at $15.99 of Entrada Therapeutics, Inc.16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAzenta Life Sciences, Board member
- 2
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Mar 3, 2026
- 7SEC EDGARForm 4 filed Sep 4, 2025
- 8SEC EDGARForm 4 filed Mar 4, 2025
- 9SEC EDGARForm 4 filed Feb 11, 2025
- 10SEC EDGARForm 4 filed Sep 5, 2024
- 11SEC EDGARForm 4 filed Jul 16, 2024
- 12SEC EDGARForm 4 filed Jun 14, 2024
- 13SEC EDGARForm 4 filed May 20, 2024
- 14SEC EDGARForm 4 filed Mar 5, 2024
- 15SEC EDGARForm 4 filed Feb 20, 2024
- 16SEC EDGARForm 4 filed Jan 18, 2024